Jane Street’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-742,100
| Closed | -$22M | – | 10411 |
|
|
2023
Q4 | $22M | Buy |
742,100
+527,100
| +245% | +$10.5M | 0.01% | 1190 |
|
|
2023
Q3 | $3.41M | Sell |
215,000
-183,800
| -46% | -$3.06M | ﹤0.01% | 3173 |
|
|
2023
Q2 | $7.53M | Buy |
398,800
+284,500
| +249% | +$3.36M | ﹤0.01% | 2225 |
|
|
2023
Q1 | $439K | Buy |
114,300
+23,400
| +26% | +$99.7K | ﹤0.01% | 6535 |
|
|
2022
Q4 | $451K | Buy |
90,900
+19,900
| +28% | +$108K | ﹤0.01% | 6316 |
|
|
2022
Q3 | $339K | Sell |
71,000
-44,800
| -39% | -$236K | ﹤0.01% | 7381 |
|
|
2022
Q2 | $521K | Buy |
115,800
+24,600
| +27% | +$107K | ﹤0.01% | 6664 |
|
|
2022
Q1 | $434K | Sell |
91,200
-248,300
| -73% | -$1.37M | ﹤0.01% | 7741 |
|
|
2021
Q4 | $2.52M | Buy |
339,500
+122,500
| +56% | +$761K | ﹤0.01% | 4017 |
|
|
2021
Q3 | $1.23M | Buy |
217,000
+126,300
| +139% | +$730K | ﹤0.01% | 5500 |
|
|
2021
Q2 | $598K | Buy |
90,700
+27,500
| +44% | +$192K | ﹤0.01% | 6909 |
|
|
2021
Q1 | $512K | Buy |
63,200
+36,600
| +138% | +$299K | ﹤0.01% | 6761 |
|
|
2020
Q4 | $172K | Buy |
26,600
+3,100
| +13% | +$18.1K | ﹤0.01% | 7023 |
|
|
2020
Q3 | $85K | Buy |
23,500
+13,200
| +128% | +$53.3K | ﹤0.01% | 6796 |
|
|
2020
Q2 | $47K | Buy |
+10,300
| New | +$43.8K | ﹤0.01% | 6878 |
|
|
2018
Q3 | – | Sell |
-11,100
| Closed | -$108K | – | 5855 |
|
|
2018
Q2 | $108K | Buy |
+11,100
| New | +$117K | ﹤0.01% | 4718 |
|
|
2017
Q4 | – | Sell |
-38,300
| Closed | -$293K | – | 5316 |
|
|
2017
Q3 | $293K | Buy |
+38,300
| New | +$254K | ﹤0.01% | 3721 |
|
Other funds holding IMGN
Jane Street's IMGN Position: Q1 2024 in Review
Jane Street sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 634,353 shares — an estimated $18.8M sold.
Jane Street first reported a position in IMGN in Q2 2013 and held it in 29 quarters. The position peaked at $18.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Jane Street reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Jane Street sold 634,353 Immunogen Inc shares in Q1 2024, an estimated $18.8M.
- Jane Street first reported a position in Immunogen Inc in Q2 2013 and held it in 29 quarters.
- Jane Street's Immunogen Inc position peaked at $18.8M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.